Bioengineered
Volume 12, 2021 - Issue 2
Open access
1,913
Views
12
CrossRef citations to date
0
Altmetric
Research paper
LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer
Mingkun Zhanga Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, the Fourth Military Medical University, Xi’an, ChinaView further author information
, Liu Yanga Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, the Fourth Military Medical University, Xi’an, ChinaView further author information
, Lan Houa Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, the Fourth Military Medical University, Xi’an, ChinaView further author information
& Xueyuan Tangb Department of Reproductive Endocrinology, Xi’an International Medical Center Hospital, Xi’an, ChinaCorrespondence[email protected]
View further author information
View further author information
Pages 9239-9250
|
Received 19 Aug 2021, Accepted 16 Oct 2021, Published online: 22 Nov 2021
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.